Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| ECOG-ACRIN-EAQ223 | Other Identifier | DCP | |
| NCI-2023-05092 | Other Identifier | NCI CTRP |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to conduct a Hybrid Type 1 cluster-randomized, roll-out effectiveness-implementation trial in NCORP community oncology practice sites (N= 500 Black and Latino cancer patients) to evaluate the effectiveness of the EA SUPPORT intervention combining CT navigators and CT research literacy tools in improving Black and Latino patient referral and accrual to NCI-supported CTs (primary outcomes) and participant and provider awareness and knowledge of CTs (secondary outcomes) while assessing implementation factors. Also, with the CUSP2CT data, Evaluation, and Coordinating Center, conduct final site evaluation and disseminate the SUPPORT intervention to NCORP community oncology sites, research bases, and affiliated trial networks.
The purpose of this study is to conduct a Hybrid Type 1 cluster-randomized, roll-out effectiveness-implementation trial in NCORP community oncology practice sites (N= 500 Black and Latino cancer patients) to evaluate the effectiveness of the EA SUPPORT intervention combining CT navigators and CT research literacy tools in improving Black and Latino patient referral and accrual to NCI-supported CTs (primary outcomes) and participant and provider awareness and knowledge of CTs (secondary outcomes) while assessing implementation factors. Also, with the CUSP2CT data, Evaluation, and Coordinating Center, conduct final site evaluation and disseminate the SUPPORT intervention to NCORP community oncology sites, research bases, and affiliated trial networks.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | No Intervention | Participant will receive usual care | |
| Intervention | Experimental | Participant will receive intervention and receive the SUPPORT toolkit. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SUPPORT toolkit | Other | The SUPPORT toolkit comprises of the SUPPORT CT website and interaction with a SUPPORT navigator. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Participant Referral | Participant referral to any NCI-supported CT assessed at the end of the 12 months of intervention stage, which will be collected from the referral tracking sheet during the intervention | End of 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Participant Accrual | Participant accrual assessed at the end of the 12 months of intervention stage, as abstracted from the clinical trials management system and corroborated with abstracted medical records and providers' clinical notes | End of 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Provider Referral | Change in provider referral behavior assessed at 12 months after the intervention | 12 months after the intervention |
| Provider Perceptions of Clinical Trials | Change in provider perceptions of clinical trials assessed at 12 months after the intervention |
Inclusion Criteria:
Participant must be ≥ 18 years of age. Participant must self-identify as Black and/or Latino. Participant must be an oncology patient at a participating NCORP. Participant must be eligible to participate in an ECOG-ACRIN clinical trial. Participant must have the ability to understand and the willingness to sign a e-consent document.
Participant must be receiving care at a participating NCORP affiliated community oncology site.
Participant must be English or Spanish speaking to be eligible. Participant must have access to a landline, smartphone, computer, or tablet.
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Melissa A Simon, MD, MPH | Contact | (312) 503-8780 | m-simon2@northwestern.edu | |
| Elyse R Park, PhD, MPH | Contact | (617) 724-6836 | epark@mgh.harvard.edu |
| Name | Affiliation | Role |
|---|---|---|
| Melissa A Simon, MD, MPH | Eastern Cooperative Oncology Group | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Northwestern University | Recruiting | Chicago | Illinois | 60611 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 12 months after the intervention |
| Exploratory outcome | Participant referral by provider assessed at 12 months after the intervention and participant referral by clinic site assessed at 12 months after the intervention | 12 months after the intervention |
| Exploratory outcome | CUSP2CT selected common measures of (a) Participant CT Awareness and Knowledge and (b) Provider CT Awareness and Knowledge | 12 months after the intervention |